ES541194A0 - A PROCEDURE FOR THE PREPARATION OF RENINE INHIBITORS CONTAINING STATIN OR ITS DERIVATIVES. - Google Patents

A PROCEDURE FOR THE PREPARATION OF RENINE INHIBITORS CONTAINING STATIN OR ITS DERIVATIVES.

Info

Publication number
ES541194A0
ES541194A0 ES541194A ES541194A ES541194A0 ES 541194 A0 ES541194 A0 ES 541194A0 ES 541194 A ES541194 A ES 541194A ES 541194 A ES541194 A ES 541194A ES 541194 A0 ES541194 A0 ES 541194A0
Authority
ES
Spain
Prior art keywords
alkyl
glutamic acid
lys
cycloalkylalkyl
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541194A
Other languages
Spanish (es)
Other versions
ES8606397A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES541194A0 publication Critical patent/ES541194A0/en
Publication of ES8606397A1 publication Critical patent/ES8606397A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Polypeptides of formula (I) and their salts are new. R-W-W'-NH-CHR2-CHR3-CH2-COR1 (I) W = Phe, His, Leu, Tyr, 1-naphthyl-Ala or 2-phenylmethyl 2-phenylmethylpropionylene; W' = Phe, His, Leu, Tyr or Nle; when W = Phe and W' = His, then the peptide link between W and W' may be replaced by -CH(1-4C)Alkyl-NH-; R = H, amino-protecting acyl of molecular wt. up to 500, or Pro or pGlu both amino protected; R2 = H, 1-6C alkyl, Ph, 4-7C cycloalkyl, Ph-(1-3C)alkyl or 5-10C cycloalkylalkyl; R3 = OH, NH2, NHR9, NHCOR9, OR9 or OCOR9; R9 = 1-4C alkyl; R1 = A-E-B; a gp. of formula (II); NH2; 1-4C alkoxy; 5-benzylipiperazin-1-yl; 1,2,3,4-tetrahydroquinolin-1-yl or -2-yl; 1,2,3,4-tetrahydro-3-aminocarbonyl isoquinolin-2-yl or the corresp. 3-methoxycarbonyl gp.; 1,2,3,4,5,6,7,8-decahydro-3-methoxycarbonyl isoquinolin-2-yl; 2-methoxycarbonylpyrrolidin -1-yl; 2-aminocarbonylpyrrolindin-1-yl; 4-phenylmethylpiperidin-1-yl; Pro-B; or Lys-B; -X-NH-CHZ-(CH2)n-Q-CHZ1-(CH2)m-Y (II) A = Lys or Pro or when R3 = NH2, Ile; E = Phe, Gly, Ala, Val, Leu, Ile, Lys, Orn, Arg, Asp opt. gamma-esterified or Glu opt. delta-esterified; B = OR4, NR4R5, glutamic acid (-OR4)2, glutamic acid (-OR4)(-NR4R5) or glutamic acid (-NR4R5)2; R4, R5 = H, 1-4C alkyl, Ph-(1-3C)alkyl or 5-10C cycloalkylalkyl; X = absent or Ala, Ile, Lys, Pro, Orn, Arg, N-(1-4C alkyl)- or N,N-(di-(1-4C) alkyl)-Lys or -Orn; Z, Z1 = H, 1-6C alkyl, 4-7C cycloalkyl, 5-10C cycloalkylalkyl or Ph-(1-3C)alkyl; n, m = 0-6; Q = CH2, CH=CH, O, NH, CH(OH) or CO; Y = Me, Ph, COOR6, CONR6R7, NH2, benzyloxycarbonylamino, CO-glutamic acid (-OR6)2, CO-glutamic acid (OR6)(NR6R7) or CO-glutamic acid (-NR6R7); R6, R7 = H, 1-4C alkyl, Ph-(1-3C)alkyl or 5-10C cycloalkylalkyl.
ES541194A 1984-03-12 1985-03-12 New polypeptide(s) contg. statine or derivs. Expired ES8606397A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58827984A 1984-03-12 1984-03-12

Publications (2)

Publication Number Publication Date
ES541194A0 true ES541194A0 (en) 1986-04-16
ES8606397A1 ES8606397A1 (en) 1986-04-16

Family

ID=24353222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541194A Expired ES8606397A1 (en) 1984-03-12 1985-03-12 New polypeptide(s) contg. statine or derivs.

Country Status (13)

Country Link
KR (1) KR870000371B1 (en)
AT (1) ATE52519T1 (en)
DE (1) DE3577562D1 (en)
ES (1) ES8606397A1 (en)
GR (1) GR850626B (en)
HU (1) HU196833B (en)
IE (1) IE57862B1 (en)
IL (1) IL74572A (en)
NO (1) NO850975L (en)
NZ (1) NZ211403A (en)
PH (1) PH23769A (en)
YU (1) YU46085A (en)
ZA (1) ZA851832B (en)

Also Published As

Publication number Publication date
YU46085A (en) 1988-02-29
ZA851832B (en) 1986-10-29
IL74572A (en) 1989-09-28
IE57862B1 (en) 1993-05-05
ES8606397A1 (en) 1986-04-16
NO850975L (en) 1985-09-13
ATE52519T1 (en) 1990-05-15
HU196833B (en) 1989-01-30
GR850626B (en) 1985-07-11
NZ211403A (en) 1989-01-27
DE3577562D1 (en) 1990-06-13
IE850640L (en) 1985-09-12
IL74572A0 (en) 1985-06-30
KR850006940A (en) 1985-10-25
KR870000371B1 (en) 1987-03-06
HUT37442A (en) 1985-12-28
PH23769A (en) 1989-11-03

Similar Documents

Publication Publication Date Title
IL124536A (en) Pharmaceutical compositions containing a glycine uptake antagonist
GB9519077D0 (en) New heterocyclic compounds
MY106287A (en) Acid addition salts of amidated taurine or glycine, their preparation and use
GR852541B (en)
DK0703923T3 (en) Factor VII derived peptides
ES541194A0 (en) A PROCEDURE FOR THE PREPARATION OF RENINE INHIBITORS CONTAINING STATIN OR ITS DERIVATIVES.
NO894720L (en) PHARMASOEYTIC ACTIVE PROTEIN.
DE3586936D1 (en) Peptide.
KR930703348A (en) Factor II (IIa) Inhibitors
FR2575163B1 (en) REDUCED TRI- AND TETRAPEPTIDES INHIBITORS OF GASTRIC SECRETION, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69102069D1 (en) 5-AMINOSALICYLIC ACID DERIVATIVES FOR THE TREATMENT OF CHRONICALLY INFLAMMABLE BELLY DISEASES.
ATE25984T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
ATE92078T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
DE3867039D1 (en) VINCRISTIN CONTAINING PRODUCT.
DE69219574D1 (en) Bradykinin antagonists used to treat acute pancreatitis
TW340849B (en) Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401